From: Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
Characteristics | N = 6 |
---|---|
Age (yrs.) | |
Median (Range) | 43.5 (24–65) |
Sex | |
Male | 4 |
Female | 2 |
KPS | |
Median (Range) | 85 (70–90) |
> 80 | 3 |
≤ 80 | 3 |
No. of seeds | |
Average (Range) | 55 (21–100) |
Extent of Resection postbrachytherapy | |
Gross total resection | 6 |
Partial resection | 0 |
Biopsy | 0 |
EBRT Pre-125I | |
Yes | 1 |
No | 5 |
Adjuvant chemotherapy-Pre | / |
Yes | 2 |
No | 4 |
Tumor position | |
Frontal lobe | 4 |
Occipital lobe | 0 |
Parietal lobe | 1 |
Temporal lobe | 0 |
Hippocampus | 1 |
Tumor location | |
Left hemisphere | 3 |
Right hemisphere | 3 |
Both hemisphere | 0 |
Tumor Diameter | |
≥5 cm | 2 |
<5 cm | 3 |
Symptoms | |
Headache | 3 |
Nausea | 1 |
Vomit | 1 |
Dizziness | 1 |
Myodynamia decline | 1 |
Vision decline | 1 |
Language disorders | 2 |
Seizures | 5 |
Histology | |
Low-grade | 3 |
High-grade | 3 |
Tumor Type | |
Recurrent | 2 |
Primary | 4 |
No. of seeds | |
Median (Range) | 65(21–113) |
PD (Gy) | 110(90–140) |